rs118192170
| Orientation | plus |
| Stabilized | plus |
| Geno | Mag | Summary |
|---|---|---|
| (C;T) | 3 | susceptibility to malignant hyperthermia |
| (T;T) | 0 | common in complete genomics |
| Make rs118192170(C;C) |
| Reference | GRCh38 38.1/141 |
| Chromosome | 19 |
| Position | 38584989 |
| Gene | RYR1 |
| is a | snp |
| is | mentioned by |
| dbSNP | rs118192170 |
| dbSNP (classic) | rs118192170 |
| ClinGen | rs118192170 |
| ebi | rs118192170 |
| HLI | rs118192170 |
| Exac | rs118192170 |
| Gnomad | rs118192170 |
| Varsome | rs118192170 |
| LitVar | rs118192170 |
| Map | rs118192170 |
| PheGenI | rs118192170 |
| Biobank | rs118192170 |
| 1000 genomes | rs118192170 |
| hgdp | rs118192170 |
| ensembl | rs118192170 |
| geneview | rs118192170 |
| scholar | rs118192170 |
| rs118192170 | |
| pharmgkb | rs118192170 |
| gwascentral | rs118192170 |
| openSNP | rs118192170 |
| 23andMe | rs118192170 |
| SNPshot | rs118192170 |
| SNPdbe | rs118192170 |
| MSV3d | rs118192170 |
| GWAS Ctlg | rs118192170 |
| Max Magnitude | 3 |
| ClinVar | |
|---|---|
| Risk | rs118192170(C;C) |
| Alt | rs118192170(C;C) |
| Reference | Rs118192170(T;T) |
| Significance | Other |
| Disease | Central core disease Malignant hyperthermia not provided |
| Variation | info |
| Gene | RYR1 |
| CLNDBN | Central core disease Malignant hyperthermia, susceptibility to, 1 not provided |
| Reversed | 0 |
| HGVS | NC_000019.9:g.39075629T>C |
| CLNSRC | OMIM Allelic Variant UniProtKB (protein) |
| CLNACC | RCV000013843.25, RCV000013844.3, RCV000119552.1, |
rs118192170, aka p.Ile4898Thr or p.I4898T, is a SNP in the RYR1 gene associated with both malignant hyperthermia and central core disease when heterozygous.
23andMe name: i6017636
[PMID 10097181
] A mutation in the transmembrane/luminal domain of the ryanodine receptor is associated with abnormal Ca2+ release channel function and severe central core disease.
[PMID 11741831] Identification of four novel mutations in the C-terminal membrane spanning domain of the ryanodine receptor 1: association with central core disease and alteration of calcium homeostasis.
[PMID 16621918] Central core disease is due to RYR1 mutations in more than 90% of patients.
[PMID 17081152] Malignant hyperthermia and central core disease causative mutations in Swedish patients.
